Gastroenterology

Papers
(The H4-Index of Gastroenterology is 93. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)
ArticleCitations
An Unusual Case of Gallbladder Emergency725
SOX9 Expression Pattern and Its Prognosis in Gastric Cancer Should be Fully Evaluated606
In Memoriam: David A. Ahlquist, MD578
Editorial Board553
Elsewhere in The AGA Journals (Preview Section)518
Spotlight462
Mo1129 PHASE 3 BIOMARKER STUDY FOR HCC SURVEILLANCE USING A NOVEL HES V2.0 ALGORITHM. A PROSPECTIVE COLLECTION WITH RETROSPECTIVE BLINDED EVALUATION427
Information for Authors and Readers422
Elsewhere in The AGA Journals405
Clinical Decision Support Tool: IBS Treatment356
Table of Contents348
Cover 1346
Editorial Board327
Sa1247 NEW INSIGHTS ON THE MECHANISM OF ACTION OF HYOSCINE BUTYLBROMIDE (HBB) IN THE HUMAN COLON: HBB MODULATES EFFECT OF NEURONAL AND NON-NEURONAL ACETYLCHOLINE261
Sa1244 BIOPHYSICAL PROPERTIES OF GASTROINTESTINAL SMOOTH MUSCLE CELL MECHANOGATED CHANNEL TMEM63A236
224 EXTERNAL VALIDATION OF A DEEP LEARNING MODEL FOR WHOLE SLIDE IMAGE ANALYSIS IN THE HISTOLOGIC DIAGNOSIS OF DYSPLASTIC BARRETT'S ESOPHAGUS226
288 OPTICAL COHERENCE TOMOGRAPHY GUIDED LASER CAPTURING OF GASTROINTESTINAL TRACT TISSUE FOR GENOMIC ANALYSIS225
699 SAFETY OUTCOMES AND CONCOMITANT MEDICATION CHANGES IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE BEING TREATED WITH RBX2660 FOR RECURRENT CLOSTRIDIOIDES DIFFICILE INFECTION221
855 CAN CYTOSPONGE HELP TRIAGE PATIENTS WHO CAN BE DISCHARGED FROM BARRETT'S SURVEILLANCE PROGRAMMES? A 2-YEAR SINGLE SITE UK STUDY212
Su1807 IBD MEDICATION USE IN PREGNANCY IS ASSOCIATED WITH A LOW RATE OF CONGENITAL ANOMALIES IN NEONATES: RESULTS FROM AN ANALYSIS OF THE BRITISH COLUMBIA POPULATION DATABASE.200
Su1776 EARLY AND RAPID USTEKINUMAB ADOPTION FOR INFLAMMATORY BOWEL DISEASE TREATMENT198
Tu1103 CROSS-SECTIONAL VS. LONG-TERM ADHERENCE TO COLORECTAL SCREENING IN A LARGE VA COHORT194
Tu1924 FORGOTTEN BUT STILL RELEVANT: VITAMIN C DEFICIENCY IN CHILDREN WITH COMPLEX MEDICAL PROBLEMS193
Mo1501 A NOVEL PROGNOSTIC MODEL USING DONOR AND RECIPIENT CHARACTERISTICS TO PREDICT EARLY POST-TRANSPLANT MORTALITY IN PATIENTS WITH ACUTE LIVER FAILURE193
Mo1532 ANTIVIRAL TREATMENT AND ITS RESPONSE REDUCE DEVELOPMENT OF DEMENTIA AMONG HEPATITIS C VIRUS INFECTED PATIENTS IN THE U.S.193
Tu1493 RISK FACTORS OF DEVELOPING NONALCOHOLIC FATTY LIVER DISEASE FOLLOWING PANCREATIC RESECTION: A SYSTEMATIC REVIEW AND META-ANALYSIS190
991 COST-EFFECTIVENESS OF RISK-STRATIFIED POST-HEPATECTOMY CARE PATHWAY IMPLEMENTATION185
Tu1525 ALL THE MORE PEOPLE TO SCREEN: A LASTING IMPACT OF A QUALITY IMPROVEMENT INITIATIVE TO INCREASE HEPATITIS C SCREENING IN AN UNDERINSURED POPULATION184
Sa1563 DEVELOPMENT AND VALIDATION OF A NOMOGRAM TO BETTER PREDICT SARCOPENIA IN NAFLD PATIENTS: AN INSIGHT FROM THE NHANES 2017-2018183
228 LAPAROSCOPIC DISTAL PANCREATECTOMY BY RADICAL ANTEGRADE MODULAR PANCREATOSPLENECTOMY (RAMPS)182
1097 PATIENTS ADMITTED WITH ACUTE CHOLECYSTITIS AND ASSOCIATED COVID 19 HAD LESS RATES OF SAME ADMISSION CHOLECYSTECTOMY BUT NOT INCREASED MORTALITY181
Tu1750 A HIGHER VISCERAL ADIPOSE TISSUE BURDEN IS ASSOCIATED WITH HIGHER INFLIXIMAB CLEARANCE IN INFLAMMATORY BOWEL DISEASE171
Su1598 IS THERE A ROLE FOR PRE-EMPTIVE TIPS IN ACUTE VARICEAL BLEEDING? REAL WORLD DATA FROM A LOCAL ASIAN COHORT162
530 COMPARISON OF OUTCOMES FOR PATIENTS UNDERGOING SADI VS. RYGB IN 2020 AND 2021160
Sa2007 INSURANCE DELAYS BIOLOGIC AND SMALL MOLECULE TREATMENT OF PEDIATRIC IBD IN TERTIARY CARE CENTER156
Sa1916 THE EFFECT OF TEDUGLUTIDE ON THE UTILIZATION OF ENTERAL NUTRIENTS FOR THE SYNTHESIS OF HEPATIC, PANCREATIC AND MUCOSAL PROTEINS IN PATIENTS WITH SHORT BOWEL SYNDROME155
Sa2001 GROWTH OUTCOMES OF IV ANTI-TNF BIOSIMILARS IN PEDIATRIC INFLAMMATORY BOWEL DISEASE152
Sa1834 VISCERAL ADIPOSITY INDEPENDENTLY PREDICTS TIME TO FLARE IN INFLAMMATORY BOWEL DISEASE, BUT BMI DOES NOT151
Sa1829 TEMPORAL TRENDS IN 30-DAY AND 90-DAY HOSPITAL RE-ADMISSION RATES AMONG PERSONS WITH CROHN'S DISEASE IN THE POSTBIOLOGIC ERA: A POPULATION-BASED STUDY FROM A LARGE CANADIAN PROVINCE147
Sa1779 THE EPIDEMIOLOGY AND CHARACTERISTICS OF DE NOVO IBD AFTER SOLID ORGAN OR HEMATOPOIETIC STEM CELL TRANSPLANT BETWEEN 2011-2021: A LARGE POPOULATION-BASED STUDY147
CME Exam 3: Abdominal Pain in a Young Adult146
Nausea, Vomiting, and Abdominal Distention After Atrial Fibrillation Therapy145
Conventional Endoscopic Mucosal Resection Versus Underwater Endoscopic Mucosal Resection: Is the Choice Straightforward?143
Efficacy and Safety of Drugs for Gastroparesis: Dopamine Receptor Antagonists Should Not Be Considered as a Single Pharmacologic Entity141
Reply140
1042 MEDICATIONS AND RISK OF MICROSCOPIC COLITIS: A NATIONWIDE COHORT STUDY132
560 SELECT AMINO ACIDS (AA-ORS) IMPROVE ELECTROLYTE AND FLUID ABSORPTION IN A RODENT DIARRHEA MODEL131
756 ELEVATED DIACYLGLYCEROL O-ACYLTRANSFERASES 1 AND 2 (DGAT1/2) REINFORCE A NEGATIVE REGULATORY LOOP OF LIPID DROPLETS AND FOXO3 TRANSCRIPTION FACTOR THAT DRIVES METABOLIC AND TUMEROGENIC REMODELING 129
1123 LOSS OF INTESTINAL EPITHELIAL DUOX2 SIGNALING IS ACCOMPANIED BY A REDUCTION IN AKKERMANSIACEAE AND PROMOTES THE DEVELOPMENT OF METABOLIC SYNDROME IN A MICROBIOME-DEPENDENT MANNER.128
1136 IMPROVED HEPATOCELLULAR CARCINOMA SURVEILLANCE WITH ANALYTICAL QUALITY IMPROVEMENT MEASURES, ELECTRONIC MEDICAL RECORD ALERTS COMBINED WITH PATIENT EDUCATION AND OUTREACH FOR PATIENTS WITH CIRRHO128
954 MESENCHYMAL STEM CELLS AMELIORATE INFLAMMATION IN AN EXPERIMENTAL MODEL OF CROHN'S DISEASE VIA THE MESENTERY125
140 FRAILTY IS ASSOCIATED WITH HIGHER IN-HOSPITAL MORTALITY, COMPLICATIONS AND HOSPITAL COST IN PATIENTS ADMITTED WITH DECOMPENSATED CIRRHOSIS: A NATIONWIDE STUDY.124
934 GERD-INDUCED ALTERATIONS IN HYDROGEN SULFIDE SIGNALING AS THE FUNDAMENTAL MECHANISM OF BARRETT'S ESOPHAGUS PATHOGENESIS124
1027 EFFICACY AND SAFETY OF INTRAVENOUS USTEKINUMAB REINDUCTION THERAPY IN CROHN'S DISEASE PATIENTS WITH SECONDARY LOSS OF RESPONSE TO USTEKINUMAB MAINTENANCE THERAPY: WEEK 16 RESULTS FROM THE POWER T124
478 NON-CANONICAL ACTIVIN A SIGNALING STIMULATES CONTEXTDEPENDENT AND CELLULAR-SPECIFIC OUTCOMES IN CRC TO PROMOTE TUMOR CELL MIGRATION AND TOLERANCE123
Sa1526 INTERNAL BILIARY STENTS AND BILIARY COMPLICATIONS AFTER LIVER TRANSPLANTATION: 16 YEARS OF EXPERIENCE IN A SINGLE CENTER122
Sa1525 RECENT IMMIGRANTS AND REFUGEES HAVE EQUAL RATES OF LIVER TRANSPLANTATION IN THE SETTING OF UNIVERSAL HEALTHCARE121
Sa1142 EFFECTS OF BIOLOGIC THERAPY IN PRIMARY SCLEROSING CHOLANGITIS WITH AND WITHOUT INFLAMMATORY BOWEL DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS121
Sa1193 RATIONALE FOR NEW SURVEILLANCE GUIDELINES FOR PATIENTS AT RISK OF PERITONEAL METASTASIS FROM COLON CANCER121
Sa1118 CHARACTERIZING DISEASE BURDEN AND RISK FACTORS IN LARYNGOPHARYNGEAL REFLUX DISEASE119
157 NEOPLASTIC PROGRESSION OF BARRETT'S ESOPHAGUS AMONG ORGAN TRANSPLANT RECIPIENTS: A CASE-CONTROL STUDY118
Mo1508 HOSPITAL TEACHING STATUS AND OUTCOMES IN PATIENTS WITH ESOPHAGEAL VARICEAL BLEEDING- A RETROSPECTIVE COHORT STUDY118
Tu1452 ARTIFICIAL INTELLIGENCE ASSISTANCE OF PANCREATIC EXOCRINE INSUFFICIENCY EVALUATION IN CHRONIC PANCREATITIS FROM CONTRAST-ENHANCED CT116
489 EATING HABITS AND SPECIFIC FOODS AND THEIR ASSOCIATION WITH GASTROINTESTINAL SYMPTOMS IN PATIENTS WITH FUNCTIONAL DYSPEPSIA AND IBS116
Mo1521 THE GLOBAL BURDEN OF ALCOHOL-ASSOCIATED CIRRHOSIS AND CANCER IN YOUNG ADULTS115
Mo1532 PRESENCE OF MENTAL HEALTH DISORDERS IN PATIENTS WITH ALCOHOL USE REDUCES THE CHANCES FOR HEPATOLOGY REFERRAL DESPITE A HIGH FIB-4 INDEX112
Mo1886 VALIDATION OF THE USE OF ARTIFICIAL INTELLIGENCE FOR CLASSIFICATION OF ULCERATIVE COLITIS VS CROHN'S DISEASE IN PEDIATRIC PATIENTS111
Su1847 COMMUNICATING NEEDS AND FEATURES OF IBD EXPERIENCES (CONFIDE) SURVEY: IMPACT OF MODERATE-TO-SEVERE CROHN'S DISEASE SYMPTOMS ON HEALTH CARE PROFESSIONAL TREATMENT DECISIONS IN THE UNITED STATES 110
Su1559 EFFECT OF ALCOHOL CONSUMPTION ON PEMAFIBRATE TREATMENT IN PATIENTS WITH FATTY LIVER AND HYPERTRIGLYCERIDEMIA110
Tu1888 METFORMIN IMPROVES INFLAMMATORY BOWEL DISEASE OUTCOMES IN PATIENTS WITH COMORBID TYPE 2 DIABETES MELLITUS110
Sa1225 DEVELOPMENT OF A PERSONALIZED HUMAN PANETH CELL MODEL USING INTESTINAL ORGANOIDS109
Tu1617 INTEGRATION OF NORMOTHERMIC MACHINE PERFUSION IN A LIVER TRANSPLANT PROGRAM REDUCES WAITLIST TIME AND MORTALITY: A TWO-CENTER/ONE ENTERPRISE MODERN EXPERIENCE108
Mo1269 PERSONALIZED INTERVENTIONS FOR ESOPHAGEAL DYSMOTILITY PREVENTS EXTRA-ESOPHAGEAL COMPLICATIONS AND IMPROVES SURGICAL OUTCOMES IN LUNG TRANSPLANT RECIPIENTS107
Mo1592 ANALYSIS OF INPATIENT ADMISSIONS AND MORTALITY RATE OF AUTOIMMUNE HEPATITIS (AIH), PRIMARY BILIARY CIRRHOSIS (PBC), AND PRIMARY SCLEROSING CHOLANGITIS (PSC): A UNITED STATES NATIONWIDE STUDY.106
Mo1750 EXPLORING THE RELATIONSHIP BETWEEN THE MEDITERRANEAN DIET AND BARRIER FUNCTION IN ULCERATIVE COLITIS106
Sa1611 HEPATITIS B VIRUS REACTIVATION IN CANCER PATIENTS RECEIVING CHEMOTHERAPY – A SYSTEMATIC REVIEW AND META-ANALYSIS106
Tu1958 INVESTIGATION OF FEEDING TUBE LONGEVITY FOR PERCUTANEOUS ENDOSCOPIC GASTROJEJUNOSTOMY (PEGJ) VS. DIRECT PERCUTANEOUS ENDOSCOPIC JEJUNOSTOMY (DPEJ) TUBES106
Sa2035 IBD PATIENT-DERIVED INTESTINAL ORGANOID PLATFORM FOR PRECISION MEDICINE105
Su1040 EFFECTS OF AN INTERVENTIONAL RADIOLOGY GUIDED TRAINING PROGRAM ON PARACENTESIS COMPETENCY AMONG INTERNAL MEDICINE RESIDENTS104
Su1948 APRAGLUTIDE TREATMENT IN SHORT BOWEL SYNDROME WITH INTESTINAL FAILURE (SBS-IF) AND COLON-IN-CONTINUITY (CIC) IS ASSOCIATED WITH INCREASED ORAL INTAKE AND IMPROVED ENERGY AND CARBOHYDRATE ABSORP102
436 POSTOPERATIVE COMPLICATIONS TREND AFTER ILEO-J-POUCH-ANAL ANASTOMOSIS FOR INFLAMMATORY BOWEL DISEASE. A SYSTEMATIC LITERTURE REVIEW102
531 THE CONDITIONAL MUTATED RAD21 KNOCK-IN MOUSE MODEL FOR CHRONIC INTESTINAL PSEUDO-OBSTRUCTION: NEUROCHEMICAL AND FUNCTIONAL ANALYSIS102
533 REGIONAL MICROBIOTA MISMATCHES FROM FECAL MICROBIOTA TRANSPLANTS DRIVE PERSISTENT, OFF-TARGET CONSEQUENCES TO THE HOST100
829 UNDERSTANDING FRAGMENTED PANCREATIC CANCER CARE IN PATIENTS RECIEVING NEOADJUVANT THERAPY: ARE SOCIODEMOGRAPHIC DISPARITIES PREDICTIVE OF PATIENTS RECEIVING FRAGMENTED CARE?100
Sa1582 IN A NATIONAL COHORT OF VETERANS WITH SBP, SECONDARY SBP PROPHYLAXIS LINKS WITH GREATER SBP RECURRENCE COMPARED TO THOSE NOT STARTED ON PROPHYLAXIS AND THIS BURDEN IS WORSENING OVER TIME100
Tu2022 DEVELOPMENT OF AN ARTIFICIAL INTELLIGENCE MODEL TO IDENTIFY DUODENAL POLYPS IN PATIENTS WITH FAMILIAL ADENOMATOUS POLYPOSIS99
847 METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE (MASLD) AND NONALCOHOLIC FATTY LIVER DISEASE (NAFLD): CONCORDANCE OF CLINICAL PROFILES AND NON-INVASIVE TESTS PERFORMANCE99
Su1524 GENETIC BIOMARKERS PREDICTING PROGNOSIS IN PATIENTS WITH CHOLANGIOCARCINOMA; A BIOINFORMATICS APPROACH STUDY98
Su1816 CAPILLARY BLOOD BASED SELF COLLECTION DEVICE FOR INFLIXIMAB THERAPEUTIC DRUG MONITORING97
Tu1996 USE OF AN AUTOMATED, DEEP LEARNING SOFTWARE TO EVALUATE BODY COMPOSITION INCLUDING SKELETAL MUSCLE MASS AND VISCERAL ADIPOSITY IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE96
Mo1591 ASSESSMENT OF THE DRUG-DRUG INTERACTION POTENTIAL OF ELAFIBRANOR WITH INDOMETHACIN IN HEALTHY ADULT MALE PARTICIPANTS: AN OPEN-LABEL PHASE I TRIAL96
Sa2047 MACHINE LEARNING-BASED INTEGRATION DEVELOPS A PLASMA EXTRACELLULAR VESICLE LONG RNA SIGNATURE FOR THE DISTINCTION OF CHRONIC PANCREATITIS SUBJECTS FROM DISEASE AND HEALTHY CONTROL SUBJECTS94
Tu1923 DYSREGULATED LIPIDS ARE ASSOCIATED WITH GUT MICROBIAL DYSBIOSIS IN AUTOIMMUNE SCURFY MICE94
0.12126994132996